应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
SVA 科兴生物
停牌 02-02 10:14:14 EST
6.47
+0.00
0.00%
最高
6.47
最低
6.47
成交量
0.00
今开
6.47
昨收
6.47
日振幅
0.00%
总市值
3.89亿
流通市值
2.02亿
总股本
6,006万
成交额
0.00
换手率
0.00%
流通股本
3,117万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
国产甲肝疫苗独家中标阿曼两年订单
动脉网 · 01-23
国产甲肝疫苗独家中标阿曼两年订单
科兴流感疫苗在阿拉伯联合酋长国获批注册
界面 · 01-23
科兴流感疫苗在阿拉伯联合酋长国获批注册
科兴获准维持纳斯达克上市地位,需在5月11日前完成财报报送
澎湃新闻 · 01-22
科兴获准维持纳斯达克上市地位,需在5月11日前完成财报报送
纳斯达克批准科兴维持上市地位
格隆汇 · 01-22
纳斯达克批准科兴维持上市地位
Antigua法院发布临时命令,授予科兴生物董事会控制权,直至2025年股东大会争议审判
投资观察 · 2025-12-17
Antigua法院发布临时命令,授予科兴生物董事会控制权,直至2025年股东大会争议审判
科兴生物:安提瓜法院发布临时命令,授予董事会控制权直至争议2025年股东大会审理结束
美股速递 · 2025-12-17
科兴生物:安提瓜法院发布临时命令,授予董事会控制权直至争议2025年股东大会审理结束
科兴生物陷退市危机,十年内斗拖累经营与治理
新浪证券 · 2025-11-28
科兴生物陷退市危机,十年内斗拖累经营与治理
科兴生物再触退市红线 治理困局拖累美股上市地位
华夏时报网 · 2025-11-22
科兴生物再触退市红线 治理困局拖累美股上市地位
科兴生物收到纳斯达克退市通知;广誉远副总裁离任
21世纪经济报道 · 2025-11-20
科兴生物收到纳斯达克退市通知;广誉远副总裁离任
科兴生物收到纳斯达克退市通知 公司回应:计划进行听证申辩会
每日经济新闻 · 2025-11-19
科兴生物收到纳斯达克退市通知 公司回应:计划进行听证申辩会
科兴生物冲刺港股:上半年营收7亿,同比降7.9% 利润7896万
雷递网 · 2025-11-12
科兴生物冲刺港股:上半年营收7亿,同比降7.9% 利润7896万
【科兴独家中标智利流感疫苗项目 首批疫苗将于明日发往智利】SINOVAC科兴中标智利项目新闻发布会上,科兴副总裁、国际业务负责人孟伟宁介绍,1月10号,SINOVAC科兴旗下北京科兴生物制品有限公司生产的三价流感疫苗安尔来福®独家中标了智利政府2025年年度流感疫苗的全球招标,首批疫苗将于1月15日发往智利。
金融界 · 2025-01-14
【科兴独家中标智利流感疫苗项目 首批疫苗将于明日发往智利】SINOVAC科兴中标智利项目新闻发布会上,科兴副总裁、国际业务负责人孟伟宁介绍,1月10号,SINOVAC科兴旗下北京科兴生物制品有限公司生产的三价流感疫苗安尔来福®独家中标了智利政府2025年年度流感疫苗的全球招标,首批疫苗将于1月15日发往智利。
加载更多
公司概况
公司名称:
科兴生物
所属市场:
NASDAQ
上市日期:
--
主营业务:
科兴控股生物技术有限公司于1999年3月1日在安提瓜和巴布达注册成立,是一家总部位于北京的生物高新技术企业。公司主要从事于研究,开发,制造及保护免受感染性疾病的疫苗。公司还曾先后研制出全球第一支SARS冠状病毒灭活疫苗(完成I期临床研究)、中国第一支大流行流感(H5N1)疫苗以及全球第一支甲型H1N1流感疫苗,为中国乃至全球疾病预防控制做出了贡献。公司正在开发一系列新产品,包括Sabin株脊髓灰质炎灭活疫苗、23价肺炎球菌多糖疫苗、新型冠状病毒灭活疫苗及多个联合疫苗等。
发行价格:
--
{"stockData":{"symbol":"SVA","market":"US","secType":"STK","nameCN":"科兴生物","latestPrice":6.47,"timestamp":1770045254496,"preClose":6.47,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":31169000,"shares":60060702,"eps":-1.31,"marketStatus":"停牌","change":0,"latestTime":"02-02 10:14:14 EST","open":6.47,"high":6.47,"low":6.47,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.31,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1770066000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1102482000000,"exchange":"NASDAQ","adjPreClose":6.47,"volumeRatio":0},"requestUrl":"/m/hq/s/SVA","defaultTab":"news","newsList":[{"id":"2605400557","title":"国产甲肝疫苗独家中标阿曼两年订单","url":"https://stock-news.laohu8.com/highlight/detail?id=2605400557","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605400557?lang=zh_cn&edition=full","pubTime":"2026-01-23 14:18","pubTimestamp":1769149080,"startTime":"0","endTime":"0","summary":"近日,科兴甲型肝炎灭活疫苗孩尔来福®独家中标阿曼2026-2027年度公费市场项目。自2022年进入阿曼市场,科兴凭借产品质量、供应时效和物流保障等优势,逐步建立可靠信誉,最终获独家供应资格。海合会六国免疫规划疫苗此前多由跨国药企供应,此次中标意味着科兴产品质量与国际履约能力获海合会国家信任,是其中东非市场重要突破。截至目前,科兴甲肝疫苗孩尔来福®已累计向全球近50个国家和地区供应超1.3亿剂次,成为全球使用最广泛的甲肝灭活疫苗之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123143029a6a3c30a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123143029a6a3c30a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2605556400","title":"科兴流感疫苗在阿拉伯联合酋长国获批注册","url":"https://stock-news.laohu8.com/highlight/detail?id=2605556400","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605556400?lang=zh_cn&edition=full","pubTime":"2026-01-23 14:00","pubTimestamp":1769148032,"startTime":"0","endTime":"0","summary":"1月23日,据”SINOVAC科兴”消息,近日,科兴流感疫苗正式获得阿拉伯联合酋长国卫生与预防部(MOHAP)颁发的药品注册证书。截至目前,科兴季节性流感疫苗已在全球20余个国家和地区广泛使用,累计供应量已超1.2亿剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012314003297a31120&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012314003297a31120&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2605492982","title":"科兴获准维持纳斯达克上市地位,需在5月11日前完成财报报送","url":"https://stock-news.laohu8.com/highlight/detail?id=2605492982","media":"澎湃新闻","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605492982?lang=zh_cn&edition=full","pubTime":"2026-01-22 21:57","pubTimestamp":1769090264,"startTime":"0","endTime":"0","summary":"昔日凭新冠疫苗走红的科兴或有机会维持纳斯达克上市地位。1月22日晚间,科兴控股生物技术有限公司(Nasq:SVA,以下简称“科兴生物”)官网发布消息称,公司已正式获得纳斯达克听证委员会批准,将继续维持在纳斯达克全球市场的上市地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601223627701015.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601223627701015.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["QQQE","QQQJ","TQQQ","MNQmain","PSQ","USJW.SI","QYLG","NQmain","BK4007","QYLD","JEPQ","SQQQ","USAW.SI","BK1147","NVIW.SI","GPIQ","TSYW.SI","QQQY","SVA","QID","QLD"],"gpt_icon":1},{"id":"2605746006","title":"纳斯达克批准科兴维持上市地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2605746006","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605746006?lang=zh_cn&edition=full","pubTime":"2026-01-22 19:14","pubTimestamp":1769080471,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["TSYW.SI","NVIW.SI","BK4007","BK1147","QQQE","SQQQ","USJW.SI","QQQY","MNQmain","QID","USAW.SI","PSQ","QLD","QYLD","JEPQ","GPIQ","QQQJ","QQQ","QQQM","TQQQ","SVA","QYLG"],"gpt_icon":0},{"id":"1101424265","title":"Antigua法院发布临时命令,授予科兴生物董事会控制权,直至2025年股东大会争议审判","url":"https://stock-news.laohu8.com/highlight/detail?id=1101424265","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101424265?lang=zh_cn&edition=full","pubTime":"2025-12-17 20:18","pubTimestamp":1765973915,"startTime":"0","endTime":"0","summary":"12月17日(路透社) - 科兴生物科技有限公司:*科兴生物:安提瓜法院发布临时命令,授予公司董事会控制权,直至2025年股东大会争议的审判*科兴生物科技有限公司 - SSM争议听证会定于2026年4月底/5月初举行 ((路透社投资者简报;电子邮箱:reutersinvestor.briefs@thomsonreuters.com)) 来源日期/时间 = 2025年12月17日12:00:00.567 GMT","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"1104966625","title":"科兴生物:安提瓜法院发布临时命令,授予董事会控制权直至争议2025年股东大会审理结束","url":"https://stock-news.laohu8.com/highlight/detail?id=1104966625","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104966625?lang=zh_cn&edition=full","pubTime":"2025-12-17 20:07","pubTimestamp":1765973228,"startTime":"0","endTime":"0","summary":"科兴生物:安提瓜法院发布临时命令,授予董事会控制权直至争议2025年股东大会审理结束","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2586204858","title":"科兴生物陷退市危机,十年内斗拖累经营与治理","url":"https://stock-news.laohu8.com/highlight/detail?id=2586204858","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586204858?lang=zh_cn&edition=full","pubTime":"2025-11-28 15:51","pubTimestamp":1764316260,"startTime":"0","endTime":"0","summary":"11月19日,科兴生物公告称收到纳斯达克上市资格部门的退市决定函,原因在于公司未能在2025年11月11日前提交2024年年度报告。尽管公司已表示将提交听证申请以暂缓退市,但这一事件再次暴露了其长期存在的公司治理问题。 审计机构致同会计师事务所于2025年4月辞任,直接导致年报无法按时提交。 科兴生物的退市危机,表面上是审计机构变更与年报延迟所致,实则是长期公司治理混乱、控制权争夺与经营战略失衡的集中爆发。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2025-11-28/doc-infyxwfh7408453.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2585779891","title":"科兴生物再触退市红线 治理困局拖累美股上市地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2585779891","media":"华夏时报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585779891?lang=zh_cn&edition=full","pubTime":"2025-11-22 22:22","pubTimestamp":1763821375,"startTime":"0","endTime":"0","summary":"纳斯达克的一纸退市函,对已停牌六年的科兴生物下达了最后通牒,其美股上市地位命悬一线。因未按期提交2024年年度报告,科兴生物(NASDAQ:SVA)于2025年11月12日收到纳斯达克上市资格部门的退市决定函。若未能在规定时间内申请听证,公司股票将于11月21日起暂停交易并启动退市程序。这是自2019年因治理问题被停牌后,科兴生物面临的第二次退市危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511223572077338.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511223572077338.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2584722409","title":"科兴生物收到纳斯达克退市通知;广誉远副总裁离任","url":"https://stock-news.laohu8.com/highlight/detail?id=2584722409","media":"21世纪经济报道","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584722409?lang=zh_cn&edition=full","pubTime":"2025-11-20 08:06","pubTimestamp":1763597181,"startTime":"0","endTime":"0","summary":"政策动向黄果在北京调研集采中选药品质量监管工作11月18日,国家药监局党组成员、副局长黄果在北京市调研集采中选药品质量监管工作,实地走访华润双鹤药业股份有限公司,调研企业质量管理及地方药品监管部门监管情况。黄果指出,国家药监局高度重视集采药品的质量监管,在各方持续努力下,生产供应质量整体稳定可控。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511203569355255.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511203569355255.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["NVIW.SI","USJW.SI","SQQQ","USAW.SI","BK4007","03086",".IXIC","MNQmain","NQmain","TSYW.SI","QLD","QID","ARTL","BK1147","BK4139","PSQ","TQQQ","SVA"],"gpt_icon":1},{"id":"2584717948","title":"科兴生物收到纳斯达克退市通知 公司回应:计划进行听证申辩会","url":"https://stock-news.laohu8.com/highlight/detail?id=2584717948","media":"每日经济新闻","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584717948?lang=zh_cn&edition=full","pubTime":"2025-11-19 19:26","pubTimestamp":1763551600,"startTime":"0","endTime":"0","summary":"科兴生物更新了一则关于纳斯达克退市事项的进展。公司披露的信息显示,其于2025年11月12日收到纳斯达克股票市场有限责任公司(即“纳斯达克”)上市资格部发出的退市决定函。此决定是由于公司未能遵守纳斯达克上市规则5250(c)(1),未能在延长期限前及时提交截至2024年12月31日财年的年度报告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511193568947938.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511193568947938.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ARTL","USJW.SI","USAW.SI","BK4007","SVA","BK4139","QLD","PSQ","MNQmain","QID","TSYW.SI","NVIW.SI","TQQQ","03086",".IXIC","BK1147","SQQQ","NQmain"],"gpt_icon":0},{"id":"2582242993","title":"科兴生物冲刺港股:上半年营收7亿,同比降7.9% 利润7896万","url":"https://stock-news.laohu8.com/highlight/detail?id=2582242993","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582242993?lang=zh_cn&edition=full","pubTime":"2025-11-12 17:58","pubTimestamp":1762941485,"startTime":"0","endTime":"0","summary":"科兴生物制药股份有限公司(简称:“科兴生物”)日前递交招股书,准备在港交所上市。招股书显示,科兴生物2022年、2023年、2024年营收分别为13.16亿元、12.59亿元、14亿元;","market":"sh","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20251112/6389856707018815885006308.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20251112/6389856707018815885006308.jpeg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n31745/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["SVA"],"gpt_icon":0},{"id":"2503545080","title":"【科兴独家中标智利流感疫苗项目 首批疫苗将于明日发往智利】SINOVAC科兴中标智利项目新闻发布会上,科兴副总裁、国际业务负责人孟伟宁介绍,1月10号,SINOVAC科兴旗下北京科兴生物制品有限公司生产的三价流感疫苗安尔来福®独家中标了智利政府2025年年度流感疫苗的全球招标,首批疫苗将于1月15日发往智利。","url":"https://stock-news.laohu8.com/highlight/detail?id=2503545080","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503545080?lang=zh_cn&edition=full","pubTime":"2025-01-14 16:59","pubTimestamp":1736845176,"startTime":"0","endTime":"0","summary":"SINOVAC科兴中标智利项目新闻发布会上,科兴副总裁、国际业务负责人孟伟宁介绍,1月10号,SINOVAC科兴旗下北京科兴生物制品有限公司生产的三价流感疫苗安尔来福®独家中标了智利政府2025年年度流感疫苗的全球招标,首批疫苗将于1月15日发往智利。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/14165947435781.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159646","SVA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinovac.com;www.sinovac.com.cn","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":0.0147},{"period":"3month","weight":0.0145},{"period":"6month","weight":0.113},{"period":"1year","weight":0.1437},{"period":"ytd","weight":0.0147}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"科兴控股生物技术有限公司于1999年3月1日在安提瓜和巴布达注册成立,是一家总部位于北京的生物高新技术企业。公司主要从事于研究,开发,制造及保护免受感染性疾病的疫苗。公司还曾先后研制出全球第一支SARS冠状病毒灭活疫苗(完成I期临床研究)、中国第一支大流行流感(H5N1)疫苗以及全球第一支甲型H1N1流感疫苗,为中国乃至全球疾病预防控制做出了贡献。公司正在开发一系列新产品,包括Sabin株脊髓灰质炎灭活疫苗、23价肺炎球菌多糖疫苗、新型冠状病毒灭活疫苗及多个联合疫苗等。","yearOnYearQuotes":[{"month":1,"riseRate":0.272727,"avgChangeRate":-0.024621},{"month":2,"riseRate":0.7,"avgChangeRate":0.044011},{"month":3,"riseRate":0.777778,"avgChangeRate":0.016157},{"month":4,"riseRate":0.111111,"avgChangeRate":-0.050461},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.034293},{"month":6,"riseRate":0.444444,"avgChangeRate":0.023452},{"month":7,"riseRate":0.222222,"avgChangeRate":-0.027021},{"month":8,"riseRate":0.444444,"avgChangeRate":0.025862},{"month":9,"riseRate":0.666667,"avgChangeRate":0.007361},{"month":10,"riseRate":0.666667,"avgChangeRate":0.018455},{"month":11,"riseRate":0.666667,"avgChangeRate":0.055242},{"month":12,"riseRate":0.3,"avgChangeRate":-0.010006}],"exchange":"NASDAQ","name":"科兴生物","nameEN":"Sinovac Biotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科兴生物(SVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科兴生物(SVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科兴生物,SVA,科兴生物股票,科兴生物股票老虎,科兴生物股票老虎国际,科兴生物行情,科兴生物股票行情,科兴生物股价,科兴生物股市,科兴生物股票价格,科兴生物股票交易,科兴生物股票购买,科兴生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科兴生物(SVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科兴生物(SVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}